FTEK

Fuel Tech is a balance-sheet story, not an earnings story. The book is genuinely clean: $39.9M equity against just $7.25M total liabilities (0.18x), $11.9M cash (up 40% YoY and ~19% of the $63.3M market cap), no long-term debt, and — critically — positive operating cash flow of $3.02M (up 188%) on only $674K capex. That combination means dilution and solvency risk are low; at $2.06 the stock trades around 1.6x book ($1.30/share) with a real net-cash backstop. That floor is why this isn't a sell.

But the operating business has gone nowhere for five years. Revenue has oscillated in a tight $24–27M band (FY2025 $26.7M is below FY2023's $27.1M), and net income has deteriorated every single year — from breakeven in FY2021 to -$2.32M in FY2025, with diluted EPS sliding to -$0.08. Operating margin is still -13.8% and the accumulated deficit sits at -$122M. The one bright spot is gross profit up 16.6% to a 46.4% margin, but it isn't enough to drag the company into the black. The MD&A confirms the mixed picture: FUEL CHEM improved on legacy-customer order regularity and a new commercial program, while APC revenue and segment profit fell on 'customer-driven project delays and project timing,' leaving year-end APC backlog at just $7.0M.